Skip to main content
. 2019 Aug 21;2:81. doi: 10.1038/s41746-019-0156-3

Table 1.

Study populations by the covariates used in the models

SPRINT population CHS population
Characteristicsa N = 9360 N = 88,374
Age, years
Mean ± SD 67.9 ± 9.4 71.7 ± 10.7
Missing, n (%) 0 (0.0%) 0 (0.0%)
Sex
Female, n (%) 3,331 (35.6%) 41,713 (47.2%)
Male, n (%) 6,029 (64.4%) 46,661 (52.8%)
Missing, n (%) 0 (0.0%) 0 (0.0%)
Black race
No, n (%) 6,414 (68.5%) 87,456 (99.0%)
Yes, n (%) 2,946 (31.5%) 918 (1.0%)
Missing, n (%) 0 (0.0%) 0 (0.0%)
BMIb, kg/m2
Mean ± SD 29.9 ± 5.8 28.4 ± 5.0
Missing, n (%) 77 (0.8%) 260 (0.3%)
Smoking category
Never, n (%) 4,122 (44.0%) 56,790 (64.3%)
Former, n (%) 3,973 (42.4%) 17,472 (19.8%)
Current, n (%) 1,239 (13.2%) 13,166 (14.9%)
Missing, n (%) 26 (0.3%) 946 (1.1%)
Clinical/subclinical CVD
No, n (%) 7,483 (79.9%) 58,526 (66.2%)
Yes, n (%) 1,877 (20.1%) 29,848 (33.8%)
Missing, n (%) 0 (0.0%) 0 (0.0%)
Systolic BP, mmHg
Mean ± SD 139.7 ± 15.6 139.9 ± 10.0
Missing, n (%) 0 (0.0%) 0 (0.0%)
BP medication types
0–1, n (%) 3,635 (38.8%) 42,576 (48.2%)
2–3, n (%) 5,211 (55.7%) 41,842 (47.3%)
≥4, n (%) 514 (5.5%) 3,956 (4.5%) 
Missing, n (%) 0 (0.0%) 0 (0.0%)
eGFR, mL/min/1.73 m2
Mean ± SD 71.7 ± 20.6 78.2 ± 21.1
Missing, n (%) 37 (0.4%) 127 (0.1%)
Total cholesterol, mg/dL
Mean ± SD 190.1 ± 41.2 188.0 ± 38.3
Missing, n (%) 38 (0.4%) 134 (0.2%)
HDL, mg/dL
Mean ± SD 52.9 ± 14.5 50.4 ± 13.4
Missing, n (%) 38 (0.4%) 146 (0.2%)

SPRINT systolic blood pressure intervention trial, CHS Clalit Health Services, SD standard deviation, BMI body mass index, kg/m2, CVD cardiovascular disease, BP blood pressure, eGFR estimated glomerular filtration rate, mL/min/1.73 m2, HDL high-density lipoprotein

aVariables were taken from the baseline characteristics of the SPRINT population and from the available EHR information prior to January 1st, 2013 for the CHS population

bBody mass index was measured as the weight in kilograms divided by the square of the height in meters